Erlotinib therapy in non small cell lung cancer patients - survival of patients on reduced erlotinib doses
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F09%3A00036395" target="_blank" >RIV/00216224:14110/09:00036395 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Erlotinib therapy in non small cell lung cancer patients - survival of patients on reduced erlotinib doses
Original language description
The question of survival of non small cell lung cancer patients treated with reduced doses of erlotinib is broached in the paper.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FC - Pneumology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2009
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Thoracic Oncology
ISSN
1556-0864
e-ISSN
—
Volume of the periodical
4
Issue of the periodical within the volume
9
Country of publishing house
US - UNITED STATES
Number of pages
2
Pages from-to
—
UT code for WoS article
—
EID of the result in the Scopus database
—